Hemophilia
Hemophilia is a rare genetic bleeding disorder in which a person’s blood has difficulty forming clots, resulting in prolonged and sometimes fatal bleeding episodes. Hemophilia is caused by deficiencies in one of two blood-clotting proteins, clotting factor VIII or clotting factor IX. Hemophilia is a serious condition, and the main symptom is uncontrolled and excessive bleeding. In severe cases of hemophilia, bleeding can occur spontaneously, with no apparent cause. In milder cases, symptoms may only appear after a person sustains an injury or undergoes a medical procedure. There is no cure for hemophilia but it is a treatable condition. Treatment is targeted at preventing and controlling bleeding episodes. This involves the regular use of a clotting factor concentrate, an intravenous infusion of clotting factor, which is typically derived from the donated blood of healthy individuals. Additionally, people with hemophilia may receive regular injections of a medication called desmopressin, which helps the body produce its own clotting factor. Physical therapy and lifestyle changes are important parts of the management plan for people with hemophilia. Hemophilia is a serious condition and can have life-threatening complications, but understanding the condition and having access to appropriate treatment can greatly improve a person’s quality of life.
← International Journal of Bone and Mineral Metabolism